“…AMPS has good reproducibility based on the test-retest coefficient of variation (COV) in healthy subjects (COV = 10.4%) (Wang and Delwaide, 1995), and is even higher in amyotrophic lateral sclerosis (ALS) patients where the number of MU is reduced (COV = 4%) (Wang and Delwaide, 1998). A good within raters COV (between 5.8 and 9%) and between raters COV (between 13.5 and 16.4%) is also found when MUNIX is applied to abductor pollicis brevis muscle of healthy subjects (Neuwirth et al, 2016). MUNIX and AMPS were widely used in clinical studies, particularly to document the motor unit loss which characterized ALS (Wang and Delwaide, 1998;Wang et al, 2002Wang et al, , 2009Nandedkar et al, 2010;Boekestein et al, 2012;Furtula et al, 2013).…”